• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

analysts

Apellis
Pharma

Apellis' Syfovre faces tough road ahead in GA market: analyst

Despite holding the lead with its complement inhibitor Syfovre, Apellis is discovering that the geographic atrophy market is a tough nut to crack.
Fraiser Kansteiner May 14, 2025 11:10am
pills drug costs money prices cash

US drug pricing poised to continue trending upward: Cowen report

Jan 9, 2025 8:29am
broken tv screen no signal

RFK Jr.'s 'biggest threat' to pharma is possible ad ban: analyst

Nov 25, 2024 10:50am
chronic kidney disease money

New CKD drugs are promising, but not yet disruptive: report

Jun 26, 2024 10:45am
A small plant growing in a crack in the ground with a shadow of a tree behind it

ALS market to grow 15% by end of decade: report

Jun 13, 2024 11:20am
A stock ticker showing Q3 results

Sanofi, GSK and Novo benefit from currency changes: analyst

Oct 21, 2022 9:21am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings